Open AccessAn Open-Label Study of Doxazosin Extended-Release for PTSD: Findings and Recommendations for Future Research on Doxazosin
Author(s) -
Anne Richards,
Sabra S. Inslicht,
Leslie Ruoff,
Thomas J. Metzler,
Lizabeth A. Goldstein,
Christen Mary Chapman,
Samantha Q Hubachek,
Thomas C. Neylan
Publication year - 2018
Publication title -
focus the journal of lifelong learning in psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1541-4108
pISSN - 1541-4094
DOI - 10.1176/appi.focus.20170031
Subject(s) - doxazosin , psychology , medicine , blood pressure
This report presents findings from an eight-week, open-label study of doxazosin extended-release for nightmares, sleep disturbance, and overall clinical symptoms in posttraumatic stress disorder (PTSD). Recommendations for future studies of doxazosin are provided.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom